Enzo Biochem, Inc. (ENZ) Reports Q3 Loss of $0.09/Share
Enzo Biochem, Inc. (NYSE: ENZ) reported Q3 EPS of ($0.09), versus ($0.05) reported last year. Revenue for the quarter came in at $26 million, versus $25.8 million reported last year.
For earnings history and earnings-related data on Enzo Biochem, Inc. (ENZ) click here.
For earnings history and earnings-related data on Enzo Biochem, Inc. (ENZ) click here.